Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease

BJU International

Volumn 91, Issue 6, 2003, Pages 522-524

  Prieto Castro, Rafael M ^a,b   Leva Vallejo, M E ^a   Regueiro Lopez, J C ^a   Anglada Curado, F J ^a   Alvarez Kindelan, J ^a   Requena Tapia, M J ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b NONE   (Spain)

Author keywords

Colchicine; Outcome; Peyronie's disease; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; COLCHICINE; IBUPROFEN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG TOLERABILITY; EVALUATION; HUMAN; INTERMETHOD COMPARISON; MALE; MEDICAL ASSESSMENT; ONSET AGE; PAIN ASSESSMENT; PEYRONIE DISEASE; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; COLCHICINE; DRUG THERAPY, COMBINATION; HUMANS; MALE; MIDDLE AGED; PAIN; PENILE ERECTION; PENILE INDURATION; SINGLE-BLIND METHOD; VITAMIN E;

EID: 0037690876     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04134.x     Document Type: Article

References (14)

1. La Peyronie F. Sur quelques obstacles qui s'opposent a l'ejaculation naturelle de la semence. In Mein de l'Academie Royale de Chir. New Edn. Paris, 1743: 425-34
2. Schuber GE. Anatomy and pathophysiology of Peyronie's Disease and congenital deviation of the penis. Urol Int 1991; 47: 231-5
3. Chiang PH, Chiang CP, Shen MR et al. Study of changes in collagen of the tunica albuginea in venogenic impotence and Peyronie's disease. Eur Urol 1992; 21: 48-51
4. Steinberg CL. A new method of treatment of Dupuytren's contracture. Med Clin North Am 1946; 30: 221-6
5. Dominguez-Malagon HR, Alfeirȧn Ruiz A, Chavarria Xicotencatl P, Durán Hernandez MS. Clinical and cellular effects of colchicine in fibromatosis. Cancer 1992; 69: 2478-83
6. Seardino PL, Scott WW. The use of tocopherols in the treatment of Peyronie's Disease. Ann New York Acad Sci 1949; 52: 390-3
7. Fitkin J, Ho GT. Peyronie's disease: current management. Am Fam Physician 1999; 60: 549-52
8. Gelbard MK, Dorey F, James K. The natural history of Peyronie's disease. J Urol 1990; 144: 1376-9
9. Somers KD, Sismour EN, Wright GL Jr, Devince CJ Jr, Gilbert DA, Horton CE. Isolation and characterization of collagen in Peyronie's disease. J Urol 1989; 141: 629-31
10. Akkus E, Carrier S, Rehman J, Breza J, Kadioglu A, Lue TF. Is colchicine effective in Peyronie's disease? A pilot study. Urology 1994; 44: 291-5
11. El-Sakka AI, Bakircioglu ME, Bhatnagar RS, Yen TS, Dahiya R, Lue TF. The effects of colchicine on a Peyronie's-like condition in an animal mod. J Urol 1999; 161: 1980-83
12. Kadioglu A, Tefekli A, Koksal T, Usta M, Erol H. Treatment of Peyronie's disease with oral colchicine: long-term results an predictive parameters of successful outcome, Int J Impot Res 2000; 12: 169-75
13. Anderson MS, Shankey TV, Lubrano T, Mulhall JP. Inhibition of Peyronie's plaque fibroblast proliferation by biologic agents. Int J Impot Res 2000; 12 (Suppl 3): S25-31
14. Culha M, Mutlu N, Acar O, Alici B. Patient-partner satisfaction with intracavernosal medication supported with agents in selected cases of Peyronie's disease. A 10-month follow-up study. Int Urol Nephrol 1999; 31: 257-62